Guangxi Wuzhou Pharma Invests $3 Million in Israeli Firm Integra

Guangxi Wuzhou Pharmaceutical closed a $3 million investment in Integra Holdings. Integra is a biotechnology holdings company established by Yissum, the technology transfer company of the Hebrew University of Jerusalem. It boasts a portfolio of nine companies that range from pre-clinical stage to registered products. Wuzhou is expected to bring Integra products to China's market. More details.... Share this with colleagues: // //